New regulations for medical devices now require close tracking of long-term safety. These changes are an added burden for medical device companies already facing challenges in trying to find a regulatory pathway, managing disparate data sources, and reaching commercial success.

However, new tech approaches accelerated by the Covid-19 pandemic are here to help manufacturers achieve clinical, regulatory, and commercial success with greater efficiencies, adherence to timelines, and cost savings. These new technologies are robust, dynamic, and easy-to-use – and are mitigating the challenges posed by the new regulations. Download the playbook to read more, including case studies that showcase three ways to leverage the new tech:

• Driving a patient-centric trial with eConsent
• Smoothing the regulatory journey with a unified platform 
• Transforming technology that boosts pre-surgical collaboration

​